A Brief SMART Exercise Instant Messaging Support Intervention - a Pilot Study

September 14, 2021 updated by: Dr. Agnes Yuen-Kwan Lai, The University of Hong Kong

A Brief SMART Exercise With Chat-based Instant Messaging Personalised Support Intervention

Lung cancer is one of the most common cancer diseases, globally and locally. Several health benefits of increased physical activity (PA) have been reported for people with cancer. PA plays a critical role across the cancer trajectory, from prevention through to post-diagnosis and has been proposed as an alternative for improving physical and psychosocial health outcomes, reducing cancer recurrence, and cancer-specific and all-cause mortality. Although there are a variety of exercise intervention programs for cancer patients, those programs were quite intensive, requiring individuals to commit extra time and effort. Feeling of overwhelmed appointments, lack of time, other barriers, including high cost and limited access to facilities are the most frequently reported barriers that prevent people from starting and maintaining exercise. Hence, the investigators propose to use a brief messaging lifestyle modification intervention program to incorporating simple and easy-to-do patient-centred home-based lifestyle-integrated exercise into daily activities of patients with lung cancer. The aims are to explore the feasibility of using instant messaging to enhance physical activity and improve their fatigue, emotion and quality of life, and obtain feedback from patients for intervention and study design improvement.

Study Overview

Status

Recruiting

Conditions

Detailed Description

Lung cancer is one of the most common cancer, globally and locally. Patients with lung cancer are in a uniquely challenging situation in their disease, comorbidities, and treatment that may lead to worsened symptoms and many negative health consequences, including fatigue, irritability, and impaired daytime functioning. Physical activity (PA) is defined as 'any bodily movement produced by skeletal muscle that results in energy expenditure'. Several health benefits of increased PA have been reported for people with cancer. PA plays a critical role across the cancer trajectory, from prevention through to postdiagnosis and has been proposed as an alternative for improving physical and psychosocial health outcomes, reducing cancer recurrence, and cancer-specific and all-cause mortality. Although there are a variety of exercise intervention programs for cancer patients, those programs were quite intensive, requiring individuals to commit extra time and effort. Most clinicians underutilise exercise therapy, regardless of its low-cost way to improve symptoms and potential health outcomes. Feeling of overwhelmed appointments, lack of time, other barriers, including high cost and limited access to facilities are the most frequently reported barriers that prevent people from starting and maintaining exercise. Low motivation, fear to exercise, lack of knowledge about benefits are the most common barriers of engaging in physical activity for cancer patients.

Hence, the current proposal is to use a brief messaging lifestyle modification intervention program to incorporating simple and easy-to-do patient-centred home-based lifestyle-integrated exercise (light to moderate physical activity) into daily activities of patients with lung cancer.

The aims are to explore the feasibility of using instant messaging to enhance physical activity and improve their fatigue, emotion and quality of life, and obtain feedback from patients for intervention and study design improvement.

Study Type

Interventional

Enrollment (Anticipated)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Asa Choi, MA
  • Phone Number: 852-3917-6563
  • Email: asachoi@hku.hk

Study Locations

      • Hong Kong, Hong Kong
        • Recruiting
        • Queen Mary Hospital
        • Principal Investigator:
          • Agnes YK Lai, PhD
        • Contact:
        • Contact:
          • David Lam, PhD
          • Phone Number: 2255-4455
          • Email: slnga@hku.hk

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 98 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria

  • Aged 18 years and above;
  • Diagnosis of non-small cell lung cancer or small cell lung cancer
  • Fatigue symptom score ≥4 out of 10
  • Self-reported engagement of <150 minutes of moderate-intensity PA each week
  • Ambulatory and capable of all self-care activities
  • Either undergoing or finished oncology therapy and/or support care
  • Mentally, cognitively and physically fit to join the trial
  • Able to speak and read Chinese;
  • Willing to complete the patient-reported outcome questionnaire
  • Completion of the Physical Activity Readiness Questionnaire
  • Possession of a smartphone with instant messaging functions such as WhatsApp or WeChat.

Exclusion criteria

  • Those preparing for lung operation
  • Skeletal fragility
  • Serious active infection
  • Inability to walk
  • Severe respiratory insufficiency
  • Uncontrolled pain
  • Diagnosed psychiatric illness such as major depressive disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Lifestyle-integrated exercise and care support
The experimental group will receive a face-to-face group session and a package of instant messages related to lifestyle-integrated exercise and cancer-related information with personalized support.
Patients will receive (i) a face-to-face group session and a package of instant messages related to lifestyle-integrated exercise (including breathing, balance, aerobic, strength, stretching exercises), cancer-related care information and support.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in fatigue level at 6 week
Time Frame: Baseline and 6 weeks
measured by Functional Assessment of Cancer Therapy - Fatigue subscale, the higher scores, the more fatigue.
Baseline and 6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Anxiety and depressive symptoms at 6 weeks
Time Frame: Baseline and 6 weeks
measured by Hospital Anxiety and Depression Scale, Each item is answered on a 4-point scale (0-3). The scores for the seven questions on depression are added together to obtain a score ranged from 0 to 21. The higher score the more depressed. The scores for the seven questions on anxiety are added together to obtain a score ranged from 0 to 21. The higher score the more anxiety and depression symptoms.
Baseline and 6 weeks
Change in sleep quality at 6 weeks
Time Frame: Baseline and 6 weeks
measured by the Pittsburgh sleep quality index . The higher the score, the worse the quality.
Baseline and 6 weeks
Change in Health-related quality of life at 6 weeks
Time Frame: Baseline and 6 weeks
measured by the European Organization for Research and Treatment of Cancer and Lung Module. The higher scores the worse the quality.
Baseline and 6 weeks
Change in Subjective Happiness at 6 weeks
Time Frame: Baseline and 6 weeks
measured by Subjective Happiness Scale. The higher scores the more happy.
Baseline and 6 weeks
Change in Pain at 6 weeks
Time Frame: Baseline and 6 weeks
measured by a question with a scale from 0 to 10; a score of "0" indicates no pain at all, a score of "10" indicates severe pain. The higher score, the more pain.
Baseline and 6 weeks
Change in dyspnea at 6 weeks
Time Frame: Baseline and 6 weeks
measured by a question with a scale from 0 to 10; a score of "0" indicates no dyspnea at all, a score of "10" indicates severe dyspnea. The higher score, the more dyspnea.
Baseline and 6 weeks
Change in activity level at 6 weeks
Time Frame: Baseline and 6 weeks
measured by pedometer
Baseline and 6 weeks
Change in hand grip strength at 6 weeks
Time Frame: Baseline and 6 weeks
measured by a dynamometer
Baseline and 6 weeks
Change in balance at 6 weeks
Time Frame: Baseline and 6 weeks
measured by single leg stand test
Baseline and 6 weeks
Change in flexibility at 6 weeks
Time Frame: Baseline and 6 weeks
measured by chair sit and reach test
Baseline and 6 weeks
Change in sleep quality with objective measurement at 6 weeks
Time Frame: Baseline and 6 weeks
measured by activity monitor on duration of sleep and awake intervals
Baseline and 6 weeks
Change in physical activity level with objective measurement at 6 weeks
Time Frame: Baseline and 6 weeks
measured by accelerometer on the daily walking steps
Baseline and 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Agnes Lai, PhD, The University of Hong Kong

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 4, 2021

Primary Completion (Anticipated)

December 1, 2021

Study Completion (Anticipated)

December 1, 2021

Study Registration Dates

First Submitted

January 23, 2021

First Submitted That Met QC Criteria

September 14, 2021

First Posted (Actual)

September 20, 2021

Study Record Updates

Last Update Posted (Actual)

September 20, 2021

Last Update Submitted That Met QC Criteria

September 14, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • UW20-019

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

For those who want the patients data, please contact PI directly by written email.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on Brief messaging and personalized support

3
Subscribe